| 2024 |
Oligomeric Symmetry of Purine Nucleoside Phosphorylases |
| 2023 |
The pursuit of new alternative ways to eradicate Helicobacter pylori continues: Detailed characterization of interactions in the adenylosuccinate synthetase active site |
| 2023 |
Visualizing allosteric pathways in oligomeric enzymes |
| 2023 |
Exploring the structural and dynamic data |
| 2023 |
Understanding allostery in oligomeric enzymes through big data visualization |
| 2023 |
Allostery analysis of oligomeric enzymes by combining X-ray structures and MD simulations with advanced visualization |
| 2022 |
Interactions of 2,6-substituted purines with purine nucleoside phosphorylase from Helicobacter pylori in solution and in the crystal, and the effects of these compounds on cell cultures of this bacterium |
| 2022 |
Biochemical characterization of His6-tagged adenylosuccinate synthetase from Helicobacter pylori: first step towards design of new inhibitors |
| 2022 |
Sustainable mechanochemical synthesis of diamondoid ethers |
| 2022 |
Characterization of diamondoid ether self-assemblies on a HOPG surface |
| 2022 |
Search for the similarities in the crystal structures of purines as possible inhibitors of purine nucleoside phosphorylase from Helicobacter pylori |
| 2022 |
Oligomeric symmetry of purine nucleoside phosphorylases |
| 2022 |
Understanding allostery in purine nucleoside phosphorylases by machine learning and molecular dynamics interaction databases |
| 2022 |
Search for Allostery in Purine Nucleoside Phosphorylases via Database of Molecular Interactions |
| 2022 |
Structure comparison and structural alignments of oligomeric purine nucleoside phosphorylases |
| 2021 |
Personalizirana terapija karcinoma |